Denmark: A recent exploratory analysis published in Clinical Obesity has found that liraglutide, a GLP-1 receptor agonist ...

Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.

DR. Guinevere Dy-Agra, head of the Institute of Pulmonary Medicine of St. Luke’s Medical Center Global City, (center) leads the opening of the Inhaler Clinic St. Luke’s Medical Center Global City has ...

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

Healthcare providers have called on the government to ensure that there is proper education of Nigerian citizens about asthma and Chronic Obstructive Pulmonary Disease (COPD), as well as improved ...

Shortness of breath, chronic coughing, or wheezing should not be ignored as they can be signs of a pulmonary condition. A ...

The ACC issued new guidance for managing common pediatric left-to-right shunts, including ASD, VSD, and PDA, in the ...

Google’s permit request for 140 more diesel backup generators at its Fort Wayne data center has been approved by the Indiana ...

A recent study published in CHEST found that treatment-naïve adults with obesity-hypoventilation syndrome receiving a ...

By early detection of fluid in the lungs, a device allows early therapy adjustments to reduce all-cause mortality in patients ...

AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral ...

The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn Pharma filed a registration statement on Wednesday seeking to raise capital ...